Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study

References

• Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445–1456. doi:10.1056/NEJMra131539926444731
   PubMed Web of Science ®Google Scholar
• Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11(2):142–151. doi:10.1016/S1473-3099(10)70218-821272794
   PubMed Web of Science ®Google Scholar
• Pande A, Non LR, Romee R, Santos CA. Pseudozyma and other non-candida opportunistic yeast bloodstream infections in a large stem cell transplant center. Transpl Infect Dis. 2017;19(2):e12664. doi:10.1111/tid.12632
   Web of Science ®Google Scholar
• Kurtzman CP, Fell JW, Boekhout T. The Yeasts: A Taxonomic Study. 5th ed. Amsterdam: Elsevier; 2011.
   Google Scholar
• Bergman MM, Gagnon D, Doern GV. Pichia ohmeri fungemia. Diagn Microbiol Infect Dis. 1998;30(3):229–231.9572030
   PubMedGoogle Scholar
• Yang BH, Peng MY, Hou SJ, Sun JR, Lee SY, Lu JJ. Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature. Int J Infect Dis. 2009;13(6):e493–e497. doi:10.1016/j.ijid.2009.02.00319411182
   PubMed Web of Science ®Google Scholar
• Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139–3142. doi:10.1128/JCM.00319-1121715586
   PubMed Web of Science ®Google Scholar
• Kanno Y, Wakabayashi Y, Ikeda M, et al. Catheter-related bloodstream infection caused by Kodamaea ohmeri: a case report and literature review. J Infect Chemother. 2017;23(6):410–414. doi:10.1016/j.jiac.2017.01.00328188094
   PubMed Web of Science ®Google Scholar
• Hitomi S, Kumao T, Onizawa K, Miyajima Y, Wakatsuki T. A case of central-venous-catheter-associated infection caused by Pichia ohmeri. J Hosp Infect. 2002;51(1):75–77. doi:10.1053/jhin.2002.1209
   Web of Science ®Google Scholar
• Choy BY, Wong SS, Chan TM, Lai KN. Pichia ohmeri peritonitis in a patient on CAPD: response to treatment with amphotericin. Perit Dial Int. 2000;20(1):91.
   Google Scholar
• Joao I, Duarte J, Cotrim C, et al. Native valve endocarditis due to Pichia ohmeri. Heart Vessels. 2002;16(6):260–263. doi:10.1007/s00380020003412382036
   PubMed Web of Science ®Google Scholar
• Reina JP, Larone DH, Sabetta JR, Krieger KK, Hartman BJ. Pichia ohmeri prosthetic valve endocarditis and review of the literature. Scand J Infect Dis. 2002;34(2):140–141.11928850
   PubMed Web of Science ®Google Scholar
• Otag F, Kuyucu N, Erturan Z, Sen S, Emekdas G, Sugita T. An outbreak of Pichia ohmeri infection in the paediatric intensive care unit: case reports and review of the literature. Mycoses. 2005;48(4):265–269. doi:10.1111/j.1439-0507.2005.01126.x15982209
   PubMed Web of Science ®Google Scholar
• Linton CJ, Borman AM, Cheung G, et al. Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United kingdom mycology reference laboratory. J Clin Microbiol. 2007;45(4):1152–1158. doi:10.1128/JCM.02061-0617251397
   PubMedGoogle Scholar
• Zhang L, Xiao M, Wang H, et al. Yeast identification algorithm based on use of the Vitek MS system selectively supplemented with ribosomal DNA sequencing: proposal of a reference assay for invasive fungal surveillance programs in China. J Clin Microbiol. 2014;52(2):572–577. doi:10.1128/JCM.02543-1324478490
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Paul S, Sood P, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections. Clin Microbiol Infect. 2015;21(4):372–378. doi:10.1016/j.cmi.2014.11.00925658527
   PubMed Web of Science ®Google Scholar
• Deak E, Charlton CL, Bobenchik AM, et al. Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory. Diagn Microbiol Infect Dis. 2015;81(1):27–33. doi:10.1016/j.diagmicrobio.2014.09.01825446889
   PubMedGoogle Scholar
• CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard -third edition. CLSI document M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
   Google Scholar
• Zhou M, Wang Y, Liu C, et al. Comparison of five commonly used automated susceptibility testing methods for accuracy in the China Antimicrobial Resistance Surveillance System (CARSS) hospitals. Infect Drug Resist. 2018;11:1347–1358. doi:10.2147/IDR.S16679030214255
   PubMed Web of Science ®Google Scholar
• Lee JS, Shin JH, Kim MN, et al. Kodamaea ohmeri isolates from patients in a university hospital: identification, antifungal susceptibility, and pulsed-field gel electrophoresis analysis. J Clin Microbiol. 2007;45(3):1005–1010. doi:10.1128/JCM.02264-0617251396
   PubMed Web of Science ®Google Scholar
• Shin DH, Park JH, Shin JH, Suh SP, Ryang DW, Kim SJ. Pichia ohmeri fungemia associated with phlebitis: successful treatment with amphotericin B. J Infect Chemother. 2003;9(1):88–89. doi:10.1007/s10156-002-0208-z12673414
   PubMedGoogle Scholar
• Tashiro A, Nei T, Sugimoto R, et al. Kodamaea ohmeri fungemia in severe burn: case study and literature review. Med Mycol Case Rep. 2018;22:21–23. doi:10.1016/j.mmcr.2018.07.00530094134
   PubMed Web of Science ®Google Scholar
• Das K, Bhattacharyya A, Chandy M, et al. Infection control challenges of infrequent and rare fungal pathogens: lessons from disseminated Fusarium and Kodamaea ohmeri infections. Infect Control Hosp Epidemiol. 2015;36(7):866–868. doi:10.1017/ice.2015.10325998614
   PubMed Web of Science ®Google Scholar
• Sundaram PS, Bijulal S, Tharakan JA, Antony M. Kodamaea ohmeri tricuspid valve endocarditis with right ventricular inflow obstruction in a neonate with structurally normal heart. Ann Pediatr Cardiol. 2011;4(1):77–80. doi:10.4103/0974-2069.7963221677814
   PubMedGoogle Scholar
• Menon T, Herrera M, Periasamy S, Palanivelu V, Sikhamani R, Wickes B. Oral candidiasis caused by Kodamaea ohmeri in a HIV patient in Chennai, India. Mycoses. 2010;53(5):458–459. doi:10.1111/j.1439-0507.2009.01731.x19531098
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Rudramurthy SM, Kale P, et al. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre. Clin Microbiol Infect. 2014;20(2):O83–O89. doi:10.1111/1469-0691.1233724004250
   PubMed Web of Science ®Google Scholar
• Fernandez-Ruiz M, Guinea J, Puig-Asensio M, et al. Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain. Med Mycol. 2017;55(2):125–136. doi:10.1093/mmy/myw05527495321
   PubMedGoogle Scholar
• Eddouzi J, Lohberger A, Vogne C, Manai M, Sanglard D. Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals. Med Mycol. 2013;51(7):737–746. doi:10.3109/13693786.2013.80023923768242
   PubMed Web of Science ®Google Scholar
• Ng KP, Kuan CS, Kaur H, Na SL, Atiya N, Velayuthan RD. Candida species epidemiology 2000–2013: a laboratory-based report. Trop Med Int Health. 2015;20(11):1447–1453. doi:10.1111/tmi.1257726216479
   PubMed Web of Science ®Google Scholar
• Rodero L, Cuenca-Estrella M, Cordoba S, et al. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol. 2002;40(6):2266–2269. doi:10.1128/jcm.40.6.2266-2269.200212037106
   PubMed Web of Science ®Google Scholar
• Kathuria S, Singh PK, Sharma C, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI Broth microdilution, and Etest method. J Clin Microbiol. 2015;53(6):1823–1830. doi:10.1128/JCM.00367-1525809970
   PubMed Web of Science ®Google Scholar
• Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a Review of the Literature. Clin Microbiol Rev. 2017;31(1):e00029–17. doi:10.1128/CMR.00029-1729142078
   PubMed Web of Science ®Google Scholar
• Siopi M, Pournaras S, Meletiadis J. Comparative evaluation of sensititre YeastOne and CLSI M38-A2 reference method for antifungal susceptibility testing of Aspergillus spp. against Echinocandins. J Clin Microbiol. 2017;55(6):1714–1719. doi:10.1128/JCM.00044-1728330883
   PubMedGoogle Scholar
• Wang HC, Hsieh MI, Choi PC, Wu CJ. Comparison of the sensititre YeastOne and CLSI M38-A2 microdilution methods in determining the activity of amphotericin B, itraconazole, voriconazole, and posaconazole against Aspergillus Species. J Clin Microbiol. 2018;56(10):e00780–18. doi:10.1128/JCM.00780-1830093391
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Chaturvedi V, Diekema DJ, et al. Clinical evaluation of the sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. J Clin Microbiol. 2008;46(7):2155–2159. doi:10.1128/JCM.00493-0818463213
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Espinel-Ingroff A, Jones RN. Clinical evaluation of the sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole. J Clin Microbiol. 2004;42(10):4577–4580. doi:10.1128/JCM.42.10.4577-4580.200415472311
   PubMed Web of Science ®Google Scholar
• Distasi MA, Del Gaudio T, Pellegrino G, Pirronti A, Passera M, Farina C. Fungemia due to Kodamaea ohmeri: first isolating in Italy. Case report and review of literature. J Mycol Med. 2015;25(4):310–316. doi:10.1016/j.mycmed.2015.08.00226404421
   PubMed Web of Science ®Google Scholar